首页 > 最新文献

Atlas of Genetics and Cytogenetics in Oncology and Haematology最新文献

英文 中文
t(6;12)(q22;p13) ETV6/FRK
Q4 Medicine Pub Date : 2019-12-01 DOI: 10.4267/2042/70649
T. Gindina
{"title":"t(6;12)(q22;p13) ETV6/FRK","authors":"T. Gindina","doi":"10.4267/2042/70649","DOIUrl":"https://doi.org/10.4267/2042/70649","url":null,"abstract":"","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42877449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FANCB (FA complementation group B) FANCB(FA互补组B)
Q4 Medicine Pub Date : 2019-12-01 DOI: 10.4267/2042/70644
Sylvie Van Twest, A. Deans
FANCB protein is a component of the Fanconi Anemia (FA) core complex needed for DNA repair. Within the core complex, FANCB forms a protein subcomplex with two other proteins, FAAP100, and an E3 RING ligase FANCL (BL100) to monoubiquitinate FANCD2 and FANCI (ID2), a process that is defective in 95% of all FA patients. FA is a rare, genetic cancer pre-disposition syndrome characterized by chromosomal instability and hypersensitivity to DNA crosslinking agents, such as those used in chemotherapy like mitomycin C (MMC) (Kennedy D'Andrea, 2006). FANCB is the only known X-linked FA gene, and mutations account for 1% of FA cases (Alter Rosenberg, 2013).
FANCB蛋白是DNA修复所需的范可尼贫血(FA)核心复合体的一个组成部分。在核心复合体中,FANCB与另外两个蛋白FAAP100和E3 RING连接酶FANCL (BL100)形成一个蛋白质亚复合体,使FANCD2和FANCI (ID2)单泛素化,95%的FA患者都存在这一过程缺陷。FA是一种罕见的遗传性癌症易感性综合征,其特征是染色体不稳定和对DNA交联剂(如化疗中使用的丝裂霉素C (MMC))过敏(Kennedy D'Andrea, 2006)。FANCB是唯一已知的x连锁FA基因,突变占FA病例的1% (Alter Rosenberg, 2013)。
{"title":"FANCB (FA complementation group B)","authors":"Sylvie Van Twest, A. Deans","doi":"10.4267/2042/70644","DOIUrl":"https://doi.org/10.4267/2042/70644","url":null,"abstract":"FANCB protein is a component of the Fanconi Anemia (FA) core complex needed for DNA repair. Within the core complex, FANCB forms a protein subcomplex with two other proteins, FAAP100, and an E3 RING ligase FANCL (BL100) to monoubiquitinate FANCD2 and FANCI (ID2), a process that is defective in 95% of all FA patients. FA is a rare, genetic cancer pre-disposition syndrome characterized by chromosomal instability and hypersensitivity to DNA crosslinking agents, such as those used in chemotherapy like mitomycin C (MMC) (Kennedy D'Andrea, 2006). FANCB is the only known X-linked FA gene, and mutations account for 1% of FA cases (Alter Rosenberg, 2013).","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44982680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
del(6p) (loss of JARID2 and DTNBP1) in myeloid malignances del(6p) (JARID2和DTNBP1的缺失)在髓系恶性肿瘤中
Q4 Medicine Pub Date : 2019-12-01 DOI: 10.4267/2042/70614
L. Mitev
Review on 6p deletion in myeloid malignancies. The neighbor genes JARID2 and DTNBP1: possible relation and clinical relevance.
髓系恶性肿瘤6p缺失的研究进展。相邻基因JARID2和DTNBP1:可能的关系和临床相关性。
{"title":"del(6p) (loss of JARID2 and DTNBP1) in myeloid malignances","authors":"L. Mitev","doi":"10.4267/2042/70614","DOIUrl":"https://doi.org/10.4267/2042/70614","url":null,"abstract":"Review on 6p deletion in myeloid malignancies. The neighbor genes JARID2 and DTNBP1: possible relation and clinical relevance.","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48246157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRLF2 (Cytokine receptor like factor 2) 细胞因子受体样因子2
Q4 Medicine Pub Date : 2019-12-01 DOI: 10.4267/2042/70641
D. Moreno-Lorenzana, R. Juárez-Velázquez, D. Martínez-Anaya, Patricia Péez-Vera
CRLF2 is a member of type I cytokine receptor family. CRLF2 forms a functional complex with IL7 receptor α chain and thymic stromal lymphopoietin, this complex induces the activation of signal transducers and activators of transcription proteins. The overexpression of CRLF2 induced by genetic rearrangements has been described in acute lymphoblastic leukemia.
CRLF2是I型细胞因子受体家族的成员。CRLF2与il - 7受体α链和胸腺基质淋巴生成素形成功能复合物,该复合物诱导信号转导和转录蛋白激活因子的激活。基因重排诱导的CRLF2过表达已在急性淋巴细胞白血病中被描述。
{"title":"CRLF2 (Cytokine receptor like factor 2)","authors":"D. Moreno-Lorenzana, R. Juárez-Velázquez, D. Martínez-Anaya, Patricia Péez-Vera","doi":"10.4267/2042/70641","DOIUrl":"https://doi.org/10.4267/2042/70641","url":null,"abstract":"CRLF2 is a member of type I cytokine receptor family. CRLF2 forms a functional complex with IL7 receptor α chain and thymic stromal lymphopoietin, this complex induces the activation of signal transducers and activators of transcription proteins. The overexpression of CRLF2 induced by genetic rearrangements has been described in acute lymphoblastic leukemia.","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46359305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
t(10;10)(p12;q21) CTNNA3/ARHGAP21
Q4 Medicine Pub Date : 2019-12-01 DOI: 10.4267/2042/70610
J. Huret
{"title":"t(10;10)(p12;q21) CTNNA3/ARHGAP21","authors":"J. Huret","doi":"10.4267/2042/70610","DOIUrl":"https://doi.org/10.4267/2042/70610","url":null,"abstract":"","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42916690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artistic creativity and mental handicap 艺术创造力与心理障碍
Q4 Medicine Pub Date : 2019-12-01 DOI: 10.4267/2042/70617
J. Huret
{"title":"Artistic creativity and mental handicap","authors":"J. Huret","doi":"10.4267/2042/70617","DOIUrl":"https://doi.org/10.4267/2042/70617","url":null,"abstract":"","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48142279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
i(5)(p10) in hematological malignancies i(5)(p10)在血液系统恶性肿瘤中的表达
Q4 Medicine Pub Date : 2019-11-01 DOI: 10.4267/2042/70576
A. Zámečníkova
Isochromosome of the short arm of chromosome 5 is an infrequent chromosome anomaly that has been reported in myeloid, and less frequently in in lymphoid malignancies, including leukemia and lymphomas.
5号染色体短臂的等染色体是一种罕见的染色体异常,在髓系中有报道,在包括白血病和淋巴瘤在内的淋巴系统恶性肿瘤中不太常见。
{"title":"i(5)(p10) in hematological malignancies","authors":"A. Zámečníkova","doi":"10.4267/2042/70576","DOIUrl":"https://doi.org/10.4267/2042/70576","url":null,"abstract":"Isochromosome of the short arm of chromosome 5 is an infrequent chromosome anomaly that has been reported in myeloid, and less frequently in in lymphoid malignancies, including leukemia and lymphomas.","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44563492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
t(1;1)(q24;q25) RCSD1/ABL2::inv(1)(q24q25) RCSD1/ABL2 t(1;1)(q24;q25) RCSD1/ABL2: inv(1) RCSD1/ABL2
Q4 Medicine Pub Date : 2019-11-01 DOI: 10.4267/2042/70529
B. Gaillard
Review on t(1;1)(q24;q25)/inv(1)(q24q25), with data on clinics, and the genes involved
回顾t(1;1)(q24;q25)/inv(1)(q24q25),临床数据和相关基因
{"title":"t(1;1)(q24;q25) RCSD1/ABL2::inv(1)(q24q25) RCSD1/ABL2","authors":"B. Gaillard","doi":"10.4267/2042/70529","DOIUrl":"https://doi.org/10.4267/2042/70529","url":null,"abstract":"Review on t(1;1)(q24;q25)/inv(1)(q24q25), with data on clinics, and the genes involved","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45084542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kidney: Succinate dehydrogenase-deficient renal cell carcinoma 肾脏:琥珀酸脱氢酶缺陷肾细胞癌
Q4 Medicine Pub Date : 2019-11-01 DOI: 10.4267/2042/70535
P. Cin
Short communication on succinate dehydrogenasedeficient renal cell carcinoma.
琥珀酸脱氢酶缺乏型肾细胞癌的短通讯。
{"title":"Kidney: Succinate dehydrogenase-deficient renal cell carcinoma","authors":"P. Cin","doi":"10.4267/2042/70535","DOIUrl":"https://doi.org/10.4267/2042/70535","url":null,"abstract":"Short communication on succinate dehydrogenasedeficient renal cell carcinoma.","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47334836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
der(3)t(3;3)(p25-26;q12-21) der(3)t(3;3)(p25-26;q12-21)
Q4 Medicine Pub Date : 2019-11-01 DOI: 10.4267/2042/70577
A. Zamecnikova
{"title":"der(3)t(3;3)(p25-26;q12-21)","authors":"A. Zamecnikova","doi":"10.4267/2042/70577","DOIUrl":"https://doi.org/10.4267/2042/70577","url":null,"abstract":"","PeriodicalId":52212,"journal":{"name":"Atlas of Genetics and Cytogenetics in Oncology and Haematology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49335495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Atlas of Genetics and Cytogenetics in Oncology and Haematology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1